Top takeaways from Mike Ward’s fireside chat with Werner Lanthaler, CEO of Evotec

We were privileged to hear visionary insights during Mike Ward’s fascinating fireside chat with Werner Lanthaler, CEO of Evotec. In the discussion, he asked Werner to share his views about the sector and big macro issues, as well as what it takes to build a biotech. This is what we learned: The teenage Werner wanted […]

An Overview of Optimum’s 14th Annual Healthcare Investor Conference 2022

Two weeks ago, Optimum hosted its 14th Annual Healthcare Investor Conference and wow, what a fantastic event it was! After two years of disruption, we were delighted to be meeting again in person. While virtual meetings have been a fantastic boon during these difficult times, nothing can beat meeting and sharing ideas and opinions face-to-face, […]

A Q&A by Verona Pharma ahead of World Lung Cancer Day

This World Lung Day, Verona Pharma is raising awareness of the debilitating burden of respiratory diseases, most specifically Chronic Obstructive Pulmonary Disease (COPD), which affects more than 384 million patients and is the third leading cause of death worldwide. What is COPD and what are the current treatments available to those patients suffering with progressive […]

STORM Therapeutics: 2022 Winner of “Fierce 15”

The award highlights significant company growth and advancement in the field of RNA modifying enzymes (RME) as STORM aims to become the global leader in the field of RME.

Use of Inbiomotion’s MAFTEST® leads to huge reduction in breast cancer mortality

Inbiomotion, a Barcelona based company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage breast cancer patients, recently presented analyses of Phase 3 data from landmark trials.

© Optimum Strategic Communications.